| Literature DB >> 24588428 |
Mikail E Abbasov1, Brandi M Hudson, Dean J Tantillo, Daniel Romo.
Abstract
α,β-Unsaturated acylammonium salts, generated in situ fromEntities:
Year: 2014 PMID: 24588428 PMCID: PMC3985498 DOI: 10.1021/ja501005g
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419
Figure 1(a) Selected natural products and pharmaceuticals containing or derived from cis- or trans-fused bicyclic γ- or δ-lactones. (b) The described organocatalytic Diels–Alder/lactonization cascade sequence.
Selected Optimization Studies of the DALa
Yields of isolated, purified products; endo/exo ratios determined by 1H NMR analysis; ee determined by chiral-phase HPLC and only shown for endo diastereomer (see SI for details). Reaction conditions: (a) 1a, 2a, 2,6-lutidine, CH2Cl2; (b) 1b, 2b, (−)-BTM, CH2Cl2; (c) 1b, 2b, DTBP, (−)-BTM. DTBP = 2,6-di-tert-butylpyridine.
Scheme 1Enantioselective DAL Organocascade
Yields refer to isolated, purified products; endo/exo ratios determined by 1H NMR analysis; ee determined by chiral-phase HPLC. †(−)-BTM (10 mol%) was used. ‡(+)-BTM (20 mol%) was used. §(−)-BTM (5 mol%) was used.
Scheme 2Stereodivergent DAL Organocascades
Yields and ratios of isolated, purified products; ee determined by chiral-phase HPLC. Insets are single crystal X-ray structures in ORTEP format (50% probability; TIPS and 4-bromobenzyl groups are removed for clarity). Reaction conditions: 4-BrC6H4CH2NH2, THF, 23 °C, 36 h (73%). †Reaction performed with carboxylic acid 1e activated in situ by TsCl (SI, p S35).
Scheme 3Synthetic Utility of Bicyclic γ-Lactones
Figure 2Calculated transition structures for the DA step of the DAL optimized at the M06-2X/6-31G(d) level with an implicit solvent model [SMD (dichloromethane)]. Gibbs free energies in kcal/mol shown are relative to the reactants. Selected bond distances are shown (Å).
Scheme 4Postulated Reaction Pathway for the DAL